Eli Lilly and Company (LLY): A Bull Case Theory

We came across a bullish thesis on Eli Lilly and Company on Arya’s Substack by Arya. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company’s share was trading at $695.33 as of August 25th. LLY’s trailing and forward P/E were 45.45 and 30.49 respectively according to Yahoo Finance.

Tevogen Bio Holdings Inc. (TVGN) Advances AI-Driven Immunotherapy with New Patent Filing

Nestor Rizhniak/Shutterstock.com

Eli Lilly & Co. (LLY) suffered a historic ~14% drop on August 7, 2025, its steepest single-day decline in over two decades, triggered by...